Study of Efficacy and Safety of Sitagliptin in Patients of Type 2 Diabetes when Added to Insulin Therapy Alone or With Metformin

Trial Profile

Study of Efficacy and Safety of Sitagliptin in Patients of Type 2 Diabetes when Added to Insulin Therapy Alone or With Metformin

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jul 2013

At a glance

  • Drugs Sitagliptin (Primary) ; Insulins; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jul 2013 New trial record
    • 25 Jun 2013 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
    • 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top